Search results for "MENOPAUSE"

showing 10 items of 296 documents

Sex Hormones and Healthy Psychological Aging in Women

2018

Besides their key role in reproduction, estrogens have effects in several organs in the body, as confirmed by the identification of estrogen receptors (ER) in multiple tissues. Experimental evidence has shown that estrogens have significant impacts on the central nervous system (CNS), and a key question is to what extent the fall in estrogen levels in the blood that occurs with increasing age, particularly around and following the menopause, has an impact on the cognitive function and psychological health of women, specifically regarding mood. This review will consider direct effects of menopausal changes in estrogens on the brain, including cognitive function and mood. Secondary pathways w…

cognitionAgingmedicine.drug_classCognitive Neurosciencemedicine.medical_treatmentmoodCentral nervous systemPhysiologyEstrogen receptorReviewsex hormoneslcsh:RC321-57103 medical and health sciences0302 clinical medicinemedicinepsychological aging030212 general & internal medicinelcsh:Neurosciences. Biological psychiatry. Neuropsychiatrybusiness.industryCognitionmedicine.diseaseMenopausemedicine.anatomical_structureMoodEstrogenHormone therapywomenbusiness030217 neurology & neurosurgeryHormoneNeuroscienceFrontiers in Aging Neuroscience
researchProduct

Evaluation of the risk factors of asymptomatic vertebral fractures in postmenopausal women with osteopenia at the femoral neck

2016

To identify risk factors of asymptomatic vertebral fracture (aVF) in postmenopausal women with osteopenia at the femoral neck and to evaluate the association between the number of aVFs and the risk of major and hip osteoporotic fracture calculated with the FRAX(®) algorithm.Epidemiological case-series study with data collected transversally.728 postmenopausal women with osteopenia were included: 284 (39.0%) had aVF, of whom 200 (70.4%) had prior fragility fractures (FF). The likelihood of having an osteoporotic fracture in the next 10 years increased significantly with the number of aVF. The percentage of women with height loss, which was assessed as the difference between the greatest heig…

congenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyFRAXBone density030209 endocrinology & metabolismRisk AssessmentAsymptomaticGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicineBone DensityRisk FactorsEpidemiologymedicineHumanscardiovascular diseases030212 general & internal medicineAgedRetrospective StudiesFemoral neckFemur NeckHip Fracturesbusiness.industryObstetrics and GynecologyRetrospective cohort studyMiddle Agedmedicine.diseaseSurgeryPostmenopauseOsteopeniaBone Diseases Metabolicmedicine.anatomical_structureSpainMultivariate AnalysisSpinal FracturesFemalemedicine.symptombusinessRisk assessmentAlgorithmsOsteoporotic Fractures
researchProduct

Body Weight, Physical Activity, and Risk of Cancer in Lynch Syndrome

2021

Simple Summary Lifestyle modifies cancer risk in the general public. How lifestyle modifies cancer risk in individuals carrying the inherited pathogenic gene variants in DNA mismatch repair genes (Lynch syndrome) remains understudied. We conducted a retrospective study with cancer register data to investigate associations between body weight, physical activity, and cancer risk among Finnish Lynch syndrome carriers (n = 465, 54% women). The results of our study indicated that longitudinal weight gain increases cancer risk, whereas being highly physically active during adulthood could decrease cancer risk in men. Further, women were observed to be less prone to lifestyle-related risk factors …

elintavatperinnölliset tauditMENOPAUSElifestyleMUTATIONS3122 Cancershereditary non-polyposis colorectal cancerylipainoEXERCISEsuolistosyövätriskitekijätlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogenslcsh:RC254-282ArticleCOLORECTAL-CANCERESTROGENADIPOSE-TISSUEMASS INDEXAGEDEFINED FAMILIAL RISKepidemiologyepidemiologiaLynchin oireyhtymäfyysinen aktiivisuusASSOCIATIONSCancers
researchProduct

Serum inhibin A, inhibin B, pro-alphaC, and activin A levels in women with idiopathic premature ovarian failure.

2003

Serum inhibin A, inhibin B, pro-alphaC, and activin A levels in 30 women with idiopathic premature ovarian failure (POF), 30 postmenopausal women, and 30 age-matched fertile women were determined. Women with POF showed low levels of inhibin A and inhibin B, but not of activin A, whereas the levels of pro-alphaC were significantly higher than in postmenopausal women. Thus, the circulating level of pro-alphaC could be a marker for assessing residual ovarian function in women with POF.

endocrine systemInhibin amedicine.medical_specialtyendocrine system diseasesPrimary Ovarian InsufficiencyAndrologyOvarian functionInternal medicineMedicineHumansInhibinsProtein Precursorsreproductive and urinary physiologyInhibin bPostmenopausal womenbusiness.industryObstetrics and Gynecologyfemale genital diseases and pregnancy complicationsActivin aPostmenopauseIdiopathic premature ovarian failureEndocrinologyReproductive MedicineFemalebusinesshormones hormone substitutes and hormone antagonistsFertility and sterility
researchProduct

Nuclear receptor NR5A2 and bone: gene expression and association with bone mineral density

2011

El pdf del artículo es el manuscrito de autor (PMCID: PMC3682472).-- et al.

endocrine systemmedicine.medical_specialtyBone densityEndocrinology Diabetes and MetabolismReceptors Cytoplasmic and NuclearElectrophoretic Mobility Shift AssaySingle-nucleotide polymorphismIn Vitro TechniquesArticleBone and BonesCell LineBone remodelingEndocrinologyOsteoprotegerinBone DensityInternal medicineBone cellmedicineHumansPromoter Regions GeneticAgedAged 80 and overRegulation of gene expressionBone mineralOsteoblastsBonesbiologyGeneral MedicineMiddle AgedGene regulationPostmenopauseEndocrinologyOsteocalcinbiology.proteinFemaleGene expression
researchProduct

Pituitary resistance to thyroid hormone action with preserved circadian rhythm of thyrotropin in a postmenopausal woman.

1992

We assessed the 24-h behavior of circulating TSH and the dopaminergic control on TSH release in a postmenopausal woman, who had elevated levels of serum thyroid hormones and an inappropriately high concentration of serum TSH, indicating pituitary resistance to thyroid hormone action. The patient was found to have a daily profile of serum TSH similar to that of normal subjects, except for the persistently elevated 24 h levels, suggesting that alterations in thyroid hormone negative feedback control did not affect substantially circadian TSH rhythm. The acute administration of a dopamine antagonist drug (metoclopramide) resulted in a markedly elevated peak of serum TSH, similar both in the mo…

endocrine systemmedicine.medical_specialtyThyroid Hormonesendocrine system diseasesEndocrinology Diabetes and MetabolismDrug ResistanceThyrotropinThyroid Function TestsThyroid function testsHyperthyroidismEndocrinologyTRH stimulation testInternal medicinemedicineHumansCircadian rhythmmedicine.diagnostic_testbusiness.industryThyroidDopaminergicDopamine antagonistMiddle AgedBromocriptineCircadian Rhythmmedicine.anatomical_structureEndocrinologyPituitary GlandFemaleMenopausebusinesshormones hormone substitutes and hormone antagonistsHormonemedicine.drugJournal of endocrinological investigation
researchProduct

Estrogen Receptor and Vascular Aging.

2021

Cardiovascular diseases remain an age-related pathology in both men and women. These pathologies are 3-fold more frequent in men than in women before menopause, although this difference progressively decreases after menopause. The vasculoprotective role of estrogens are well established before menopause, but the consequences of their abrupt decline on the cardiovascular risk at menopause remain debated. In this review, we will attempt to summarize the main clinical and experimental studies reporting the protective effects of estrogens against cardiovascular diseases, with a particular focus on atherosclerosis, and the impact of aging and estrogen deprivation on their endothelial actions. Th…

endotheliumvascular agingGeriatricsestradiolRC952-954.6menopauseGeneral Medicineatherosclerosisestrogen receptorFrontiers in aging
researchProduct

Menopause modulates the circulating metabolome: evidence from a prospective cohort study

2022

Abstract Aims We studied the changes in the circulating metabolome and their relation to the menopausal hormonal shift in 17β-oestradiol and follicle-stimulating hormone levels among women transitioning from perimenopause to early postmenopause. Methods and results We analysed longitudinal data from 218 Finnish women, 35 of whom started menopausal hormone therapy during the study. The menopausal transition was monitored with menstrual diaries and serum hormone measurements. The median follow-up was 14 months (interquartile range: 8–20). Serum metabolites were quantified with targeted nuclear magnetic resonance metabolomics. The model results were adjusted for age, follow-up duration, educat…

estradiolivaihdevuodetEpidemiologyCholesterol HDLmenopauseoestradiolCholesterol LDLmetabolomicscardiovascular diseaseshormonaaliset tekijäthormone replacement therapyaineenvaihduntahäiriötsydän- ja verisuonitaudithormonihoitoMetabolomeHumansaineenvaihduntatuotteetFemaleProspective StudiesMenopauseCardiology and Cardiovascular MedicinekohorttitutkimusaineenvaihduntaTriglyceridesEuropean Journal of Preventive Cardiology
researchProduct

Estradiol deficiency and skeletal muscle apoptosis: Possible contribution of microRNAs.

2020

Background Menopause leads to estradiol (E2) deficiency that is associated with decreases in muscle mass and strength. Here we studied the effect of E2 deficiency on miR-signaling that targets apoptotic pathways. Methods C57BL6 mice were divided into control (normal estrous cycle, n = 8), OVX (E2 deficiency, n = 7) and OVX + E2 groups (E2-pellet, n = 4). Six weeks following the OVX surgery, mice were sacrificed and RNA isolated from gastrocnemius muscles. miR-profiles were studied with Next-generation sequencing (NGS) and candidate miRs verified using qPCR. The target proteins of the miRs were found using in silico analysis and measured at mRNA (qPCR) and protein levels (Western blot). Resu…

estrogeenit0301 basic medicineestradioliAgingmedicine.medical_specialtyvaihdevuodetcaspasemenopauseApoptosisBiochemistryArticlehormonaaliset tekijät03 medical and health sciencesMicecytochrome C0302 clinical medicineEndocrinologyWestern blotInternal medicinemicroRNAGeneticsmedicineAnimalsMuscle SkeletalMolecular BiologyCaspaseEstrous cycleMessenger RNAmedicine.diagnostic_testbiologyEstradiolsytokromitRNASkeletal muscleCell BiologyMice Inbred C57BLMicroRNAsovariectomy030104 developmental biologyEndocrinologymedicine.anatomical_structuremuscle masslihasmassaApoptosisbiology.proteinFemalemikro-RNAhormones hormone substitutes and hormone antagonists030217 neurology & neurosurgeryExperimental gerontology
researchProduct

Estrogen regulates muscle bioenergetic signaling

2018

estrogeenitAgingvaihdevuodetBioenergeticsmedicine.drug_classmenopauseBiologyta3111estrogenic regulation03 medical and health sciences0302 clinical medicinemitochondrial functionmedicinelihassolutbioenergetiikkamuscle proteome030304 developmental biology0303 health sciencesta3141Cell Biologymedicine.diseaseCell biologyMuscle proteomeMenopauseikääntyminenEstrogen030220 oncology & carcinogenesisAging
researchProduct